Trial Profile
Exploratory study to evaluate effect of ferric citrate hydrate on oxidative-stress in maintenance hemodialysis patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jul 2017
Price :
$35
*
At a glance
- Drugs Ferric citrate (Primary)
- Indications Hyperphosphataemia; Iron deficiency anaemia
- Focus Pharmacodynamics
- 04 Jul 2017 Status changed from active, no longer recruiting to completed.
- 30 May 2016 New trial record